82 related articles for article (PubMed ID: 12090548)
1. Pegvisomant. Pharmacia.
Goffin V; Touraine P
Curr Opin Investig Drugs; 2002 May; 3(5):752-7. PubMed ID: 12090548
[TBL] [Abstract][Full Text] [Related]
2. Pegvisomant Pfizer/Sensus.
Goffin V; Touraine P
Curr Opin Investig Drugs; 2004 Apr; 5(4):463-8. PubMed ID: 15134290
[TBL] [Abstract][Full Text] [Related]
3. Telithromycin. Aventis Pharma.
Johnson AP
Curr Opin Investig Drugs; 2001 Dec; 2(12):1691-701. PubMed ID: 11892930
[TBL] [Abstract][Full Text] [Related]
4. Parecoxib. Pharmacia corp.
Gotta AW
IDrugs; 2001 Aug; 4(8):939-44. PubMed ID: 15973593
[TBL] [Abstract][Full Text] [Related]
5. Pegvisomant: current and potential novel therapeutic applications.
Thankamony GN; Dunger DB; Acerini CL
Expert Opin Biol Ther; 2009 Dec; 9(12):1553-63. PubMed ID: 19916734
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone excess and the development of growth hormone receptor antagonists.
Higham CE; Trainer PJ
Exp Physiol; 2008 Nov; 93(11):1157-69. PubMed ID: 18617577
[TBL] [Abstract][Full Text] [Related]
7. [Growth hormone receptor antagonists: potential indications].
Muller AF; Janssen JA; de Herder WW; van der Lely AJ
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):69-73. PubMed ID: 11225259
[TBL] [Abstract][Full Text] [Related]
8. Treprostinil sodium Pharmacia.
Chattaraj SC
Curr Opin Investig Drugs; 2002 Apr; 3(4):582-6. PubMed ID: 12090728
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone receptor antagonists.
Kohn DT; Kopchick JJ
Minerva Endocrinol; 2002 Dec; 27(4):287-98. PubMed ID: 12511851
[TBL] [Abstract][Full Text] [Related]
10. Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.
Jørgensen JO; Feldt-Rasmussen U; Frystyk J; Chen JW; Kristensen LØ; Hagen C; Ørskov H
J Clin Endocrinol Metab; 2005 Oct; 90(10):5627-31. PubMed ID: 16046586
[TBL] [Abstract][Full Text] [Related]
11. Exubera. Inhale therapeutic systems.
Bindra S; Cefalu WT
Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
[TBL] [Abstract][Full Text] [Related]
12. Pegasys (Hoffmann-La Roche).
Barnard DL
Curr Opin Investig Drugs; 2001 Nov; 2(11):1530-8. PubMed ID: 11763153
[TBL] [Abstract][Full Text] [Related]
13. Lessons from 6 years of GH receptor antagonist therapy for acromegaly.
Trainer PJ
J Endocrinol Invest; 2003; 26(10 Suppl):44-52. PubMed ID: 15497659
[TBL] [Abstract][Full Text] [Related]
14. Valdecoxib (Pharmacia).
Gotta AW
Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.
Colao A; Pivonello R; Auriemma RS; De Martino MC; Bidlingmaier M; Briganti F; Tortora F; Burman P; Kourides IA; Strasburger CJ; Lombardi G
Eur J Endocrinol; 2006 Mar; 154(3):467-77. PubMed ID: 16498061
[TBL] [Abstract][Full Text] [Related]
16. Exisulind Cell Pathways.
Griffiths GJ
Curr Opin Investig Drugs; 2000 Nov; 1(3):386-91. PubMed ID: 11249724
[TBL] [Abstract][Full Text] [Related]
17. Discovery and uses of pegvisomant: a growth hormone antagonist.
Berryman DE; Palmer AJ; Gosney ES; Swaminathan S; DeSantis D; Kopchick JJ
Endokrynol Pol; 2007; 58(4):322-9. PubMed ID: 18058724
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs.
Herman-Bonert VS; Zib K; Scarlett JA; Melmed S
J Clin Endocrinol Metab; 2000 Aug; 85(8):2958-61. PubMed ID: 10946911
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.
Kopchick JJ; Parkinson C; Stevens EC; Trainer PJ
Endocr Rev; 2002 Oct; 23(5):623-46. PubMed ID: 12372843
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly.
Neggers SJ; van Aken MO; Janssen JA; Feelders RA; de Herder WW; van der Lely AJ
J Clin Endocrinol Metab; 2007 Dec; 92(12):4598-601. PubMed ID: 17895318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]